John Amos
Co-founder 1955Background
John Amos co-founded Aflac in 1955 alongside his brothers Paul and Bill, driven by the frustration of observing families financially ruined by the devastating costs of cancer treatment which was excluded from most major medical policies at the time. His defining founding philosophy was that everyone deserved financial protection against the catastrophic costs of critical illness, and that the most efficient way to provide that protection was through a direct, cash-benefit policy that could be sold in the workplace.
Role at Aflac Incorporated
Aflac (originally the American Family Life Insurance Company) was founded in 1955 in Columbus, Georgia, by three brothers: John, Paul, and William Amos. The brothers did not possess Wall Street backing; they raised the initial capital by selling shares door-to-door in their local community. In its early years, the company struggled significantly, selling traditional life and health insurance in a competitive, commoditized market dominated by Northern mutual insurers. The foundational breakthrough for Aflac occurred in 1958 when the Amos brothers made a radical pivot. Recognizing the devastating financial toll that cancer treatments were beginning to take on American families—expenses that traditional health insurance did not fully cover—they introduced the world's first cancer insurance policy. This was a novel concept: a supplemental policy that paid cash directly to the patient upon diagnosis, allowing them to pay for travel, experimental treatments, or simply keep the lights on while unable to work. This singular product innovation transformed Aflac from a struggling local firm into a rapidly growing national enterprise. The second, most critical decision in the founders' history occurred in 1974 when John Amos took an unprecedented risk: he traveled to Tokyo and secured a license to sell cancer insurance in Japan. At the time cancer was rapidly becoming the leading cause of death in Japan, and the national health system did not fully cover the out-of-pocket costs. Aflac's cancer policies exploded in popularity among Japanese consumers who are risk-averse and value long-term financial security. Today, the company is still led by Dan Amos (the son of co-founder Paul Amos), who has served as CEO since 1990, representing one of the longest, most successful tenures of any Fortune 500 CEO and maintaining the founding family's iron grip on the company's culture.